🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be a single-center, randomized, parallel, open-label, singl...
Status
Unknown
Location
Multiple Locations
Start Date
2020-08-20
Trial ID
NCT04527484
Treatments Being Tested
The study is being conducted to evaluate the efficacy and safety of SHR-131...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-04-29
Trial ID
NCT06860750
Treatments Being Tested
This is a multicenter, placebo-controlled, parallel-randomized, double-blin...
Status
Suspended
Location
Shanghai Hengrui Pharmaceutical Co., Ltd.
Start Date
2019-11-09
Trial ID
NCT04121143
Treatments Being Tested
This study will be a single-center, randomized, parallel, open-label, singl...
Status
Unknown
Location
Multiple Locations
Start Date
2020-04-07
Trial ID
NCT04326881
Treatments Being Tested
This study is a randomized, double-blind, multicenter, placebo-controlled P...
Status
Completed
Location
Huashan Hospital of the Shanghai FuDan University
Start Date
2021-10-22
Trial ID
NCT05055934
Treatments Being Tested
This study is a randomized, double-blind, multicenter, placebo-controlled P...
Status
Active Not Recruiting
Location
Huashan Hospital of the Shanghai FuDan University
Start Date
2024-11-04
Trial ID
NCT06640257
Treatments Being Tested
This is a single-arm, prospective, open-label, Phase II study that explored...
Status
Terminated
Location
Shanghai Ninth People's Hospital,Shanghai Jiao Tong University School of Medical
Start Date
2022-09-13
Trial ID
NCT05394857
Treatments Being Tested
This is a multiple dose escalating and open labeled clinical trial to evalu...
Status
Unknown
Location
Huanshan Hospital , Shanghai Fudan University
Start Date
2018-08-02
Trial ID
NCT03710681
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, single dose escalat...
Status
Completed
Location
Atridia Pty Limited
Start Date
2016-08-22
Trial ID
NCT02934412
The purpose of this study is to evaluate the safety and pharmacokinetics of...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2023-12-24
Trial ID
NCT06182384